Genetic mutations such as KRAS, APC, TP53, SMAD4, EGFR, and MYC regulate cancer processes in CRC by influencing cancer cell motility and metabolic reprogramming, including aerobic glycolysis [46–54]. Here, TP53 is linked to colorectal carcinoma.